Gabelli & Co Investment Advisers’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,850	Closed	-$2.42M	–	290
2023 Q4	$2.42M	Buy	+38,850	New	+$966K	0.45%	52

Gabelli & Co Investment Advisers's RYZB Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 38,850 shares — an estimated $2.42M sold.

Gabelli & Co Investment Advisers first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $2.42M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Gabelli & Co Investment Advisers reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 38,850 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $2.42M.
Gabelli & Co Investment Advisers first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's RayzeBio, Inc. Common Stock position peaked at $2.42M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.